{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:21:23Z","timestamp":1758057683607,"version":"3.44.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Scientific Research Projects of Hunan Health Commission"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ejphar.2019.172745","type":"journal-article","created":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T17:45:17Z","timestamp":1571507117000},"page":"172745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Valproic acid promotes the epithelial-to-mesenchymal transition of breast cancer cells through stabilization of Snail and transcriptional upregulation of Zeb1"],"prefix":"10.1016","volume":"865","author":[{"given":"Siyuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohua","family":"Qing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoting","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qunhuan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172745_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/gutjnl-2011-300060","article-title":"Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer","volume":"61","author":"Aghdassi","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2019.172745_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbi.2017.12.003","article-title":"Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells","volume":"280","author":"Aztopal","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2019.172745_bib3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/1389557515666150521162237","article-title":"Histone deacetylase inhibitors: a review on class-I specific inhibition","volume":"15","author":"Behera","year":"2015","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172745_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2019.172745_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1677\/joe.1.06970","article-title":"Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells","volume":"191","author":"Catalano","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2019.172745_bib6","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.21873\/anticanres.11077","article-title":"Valproic acid alters angiogenic and trophic gene expression in human prostate cancer models","volume":"36","author":"Chelluri","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejphar.2019.172745_bib7","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1515\/hsz-2016-0307","article-title":"Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1","volume":"398","author":"Chen","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172745_bib8","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00204-014-1301-z","article-title":"Bisphenol A modulates colorectal cancer protein profile and promotes the metastasis via induction of epithelial to mesenchymal transitions","volume":"89","author":"Chen","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejphar.2019.172745_bib9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1517\/13543784.2013.853037","article-title":"New perspectives of valproic acid in clinical practice","volume":"22","author":"Cincarova","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2019.172745_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-007-9402-7","article-title":"Valproic acid induces p21 and topoisomerase-II (alpha\/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines","volume":"85","author":"Das","year":"2007","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejphar.2019.172745_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10549-014-3233-y","article-title":"HDAC inhibition does not induce estrogen receptor in human triple-negative breast cancer cell lines and patient-derived xenografts","volume":"149","author":"de Cremoux","year":"2015","journal-title":"Breast Canc. Res. Treat."},{"key":"10.1016\/j.ejphar.2019.172745_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.semcancer.2009.02.007","article-title":"Epigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatment","volume":"19","author":"Dworkin","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2019.172745_bib12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2019.172745_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/19336918.2015.1112486","article-title":"Histone deacetylase inhibitor valproic acid (VPA) promotes the epithelial mesenchymal transition of colorectal cancer cells via up regulation of Snail","volume":"9","author":"Feng","year":"2015","journal-title":"Cell Adhes. Migrat."},{"key":"10.1016\/j.ejphar.2019.172745_bib14","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1442-2042.2007.01823.x","article-title":"Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo","volume":"14","author":"Gao","year":"2007","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ejphar.2019.172745_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s13402-017-0314-z","article-title":"Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells","volume":"40","author":"Gilardini Montani","year":"2017","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.ejphar.2019.172745_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058672","article-title":"Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer","volume":"8","author":"Giudice","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172745_bib17","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2019.172745_bib18","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1091\/mbc.e11-02-0103","article-title":"An autocrine TGF-beta\/ZEB\/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition","volume":"22","author":"Gregory","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejphar.2019.172745_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2018.07.057","article-title":"Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer","volume":"835","author":"Heers","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172745_bib20","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3892\/or.2015.3879","article-title":"HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells","volume":"33","author":"Ji","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2019.172745_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41236-017-0005-8","article-title":"Distinguishing mechanisms underlying EMT tristability","volume":"1","author":"Jia","year":"2017","journal-title":"Cancer Converg"},{"key":"10.1016\/j.ejphar.2019.172745_bib22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbamcr.2012.12.002","article-title":"Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression","volume":"1833","author":"Jiang","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2019.172745_bib23","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3892\/ijo.2016.3712","article-title":"Valproic acid inhibits irradiation-induced epithelial-mesenchymal transition and stem cell-like characteristics in esophageal squamous cell carcinoma","volume":"49","author":"Kanamoto","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2019.172745_bib24","doi-asserted-by":"crossref","first-page":"19341","DOI":"10.1038\/srep19341","article-title":"Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation","volume":"6","author":"Kelkar","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2019.172745_bib25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2217\/epi-2016-0034","article-title":"Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanisms","volume":"8","author":"Khan","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.ejphar.2019.172745_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045045","article-title":"Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells","volume":"7","author":"Kong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172745_bib27","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Kramer","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2019.172745_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00432-015-2020-4","article-title":"Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4","volume":"142","author":"Lan","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2019.172745_bib29","doi-asserted-by":"crossref","first-page":"18144","DOI":"10.1073\/pnas.1318192110","article-title":"MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination","volume":"110","author":"Lu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2019.172745_bib30","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1039\/C5TX00476D","article-title":"Valproic acid causes radiosensitivity of breast cancer cells via disrupting the DNA repair pathway","volume":"5","author":"Luo","year":"2016","journal-title":"Toxicol Res (Camb)"},{"key":"10.1016\/j.ejphar.2019.172745_bib31","first-page":"610495","article-title":"Migration, proliferation, and differentiation of cord blood mesenchymal stromal cells treated with histone deacetylase inhibitor valproic acid","volume":"2014","author":"Marquez-Curtis","year":"2014","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.ejphar.2019.172745_bib32","article-title":"Tackling cancer stem cells via inhibition of EMT transcription factors","volume":"2016","author":"Mladinich","year":"2016","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.ejphar.2019.172745_bib33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/stem.1544","article-title":"Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement","volume":"32","author":"Paino","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.ejphar.2019.172745_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ejphar.2019.172745_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/180363","article-title":"Mechanism of growth inhibition of prostate cancer xenografts by valproic acid","volume":"2012","author":"Sidana","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ejphar.2019.172745_bib36","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2019.172745_bib37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fonc.2018.00092","article-title":"Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi","volume":"8","author":"Suraweera","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejphar.2019.172745_bib38","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/1078-0432.CCR-03-0100","article-title":"Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells","volume":"10","author":"Takai","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2019.172745_bib39","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2019.172745_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2017.08.002","article-title":"Valproic acid sensitizes breast cancer cells to hydroxyurea through inhibiting RPA2 hyperphosphorylation-mediated DNA repair pathway","volume":"58","author":"Tian","year":"2017","journal-title":"DNA Repair"},{"key":"10.1016\/j.ejphar.2019.172745_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/156800912800190884","article-title":"An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors","volume":"12","author":"Tinari","year":"2012","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejphar.2019.172745_bib42","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1074\/jbc.M111.286138","article-title":"Studies using an in vitro model show evidence of involvement of epithelial-mesenchymal transition of human endometrial epithelial cells in human embryo implantation","volume":"287","author":"Uchida","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172745_bib43","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3892\/ol.2013.1565","article-title":"Inhibitory effect of valproic acid on bladder cancer in combination with chemotherapeutic agents in vitro and in vivo","volume":"6","author":"Wang","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejphar.2019.172745_bib44","doi-asserted-by":"crossref","first-page":"16745","DOI":"10.18632\/oncotarget.7778","article-title":"Significance of the NOR1-FOXA1\/HDAC2-Slug regulatory network in epithelial-mesenchymal transition of tumor cells","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2019.172745_bib45","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/15680096113136660102","article-title":"The role of Snail in EMT and tumorigenesis","volume":"13","author":"Wang","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejphar.2019.172745_bib46","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.biopha.2016.10.023","article-title":"Valproic acid (VPA) promotes the epithelial mesenchymal transition of hepatocarcinoma cells via transcriptional and post-transcriptional up regulation of Snail","volume":"84","author":"Wu","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2019.172745_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-011-1085-x","article-title":"VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating survivin","volume":"361","author":"Zhang","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2019.172745_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.abb.2015.09.006","article-title":"Bisphenol A stimulates the epithelial mesenchymal transition of estrogen negative breast cancer cells via FOXA1 signals","volume":"585","author":"Zhang","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2019.172745_bib49","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.biopha.2018.11.112","article-title":"The roles of ZEB1 in tumorigenic progression and epigenetic modifications","volume":"110","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2019.172745_bib50","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ccr.2014.07.022","article-title":"PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis","volume":"26","author":"Zheng","year":"2014","journal-title":"Cancer Cell"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919306971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919306971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:32:19Z","timestamp":1757975539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919306971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":51,"alternative-id":["S0014299919306971"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172745","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid promotes the epithelial-to-mesenchymal transition of breast cancer cells through stabilization of Snail and transcriptional upregulation of Zeb1","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172745"}}